NCT04100473
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Profil Mainz Mainz, Malakoff-Passage, Germany
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,014 public trials
712 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02235194
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
- Locations
-
- Stoffwechselzentrum Rhein Pfalz Mannheim, Germany
NCT02184455
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
- Locations
-
- Queen Elizabeth II Health Sciences Center Halifax, Nova Scotia, Canada
- St. Michael's Hospital Toronto, Ontario, Canada
NCT02750410
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adachi-ku, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiyoda City, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chuou-ku, Japan
NCT02973100
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Parexel Early Phase Unit at Glendale Glendale, California, United States
- Marin Endocrine Associates Greenbrae, California, United States
- National Research Institute Huntington Park, California, United States
- National Research Institute Los Angeles, California, United States
Completed
CMR in Type 2 Diabetes Mellitus Patients
NCT02684331
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- The diabetes outpatient clinic, Slagelse Hospital, Denmark Slagelse, Denmark
NCT02906709
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT00627484
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +13 more
- Locations
-
- Columbia University Medical Center New York, United States
NCT01621178
- Conditions
- Chronic Disease, Chronic Kidney Disease, Diabetes Mellitus, +17 more
- Locations
-
- Extended Arm Physician, Inc. Montgomery, Alabama, United States
- North American Research Institute Azusa, California, United States
- Renal Consultants Medical Group Granada Hills, California, United States
- Marin Endocrine Associates Greenbrae, California, United States
Completed
A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
NCT01644500
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chongqing, China